A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants
Clinical trial NCT03570658 · COMPLETED
Trial details
- NCT number
- NCT03570658
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-24
- Primary completion
- 2019-01-28
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.